AVD American Vanguard Corporation
XNYS 1.52 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $1.00 – $5.55
- YTD
- -59.97%
- Straddle Price
- $1.90
- P/C Vol Ratio
- 1.00
- Market Cap
- $0.0B
- Open
- $1.02
- Day Range
- $1.01 – $1.08
- Volume
- 221,468
- Prev Close
- $1.03
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.96% |
| Beta vs SPY | 0.95 |
| Cost of Equity (CAPM) | 9.70% (VRP-adj) |
| WACC | 5.94% |
| Volatility Risk Premium | +366.1pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -2.1% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -30.1% |
| Book / Price | 632.6% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 29.4% |
| FCF Margin (TTM) | -9.2% |
| Debt / Equity | 0.90 |
| Quality Score | 0/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $1.87 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $1.40 |
| Bollinger Width / SMA20 | 6220.1% (drives anchor stability) |
| Net Debt | $0.2B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 16.4× · 5 peers |
| Peer EV/EBITDA | $1.22 | 11% | median 11.2× · 7 peers |
| Peer P/B | $12.39 | 14% | median 1.8× · 7 peers |
| Peer P/S | $20.47 | 14% | median 1.1× · 7 peers |
| Market Anchor (SMA50) | $1.87 | 61% | stability 85% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |

- Industry (SIC)
- AGRICULTURAL CHEMICALS (2870) · industry map
- Exchange
- XNYS
- Market Cap
- $0.0B
- Employees
- 739
- List Date
- 1987-03-03
- CIK
- 0000005981
- Next Earnings
- 2026-11-09 (Pre-Market)
- Headquarters
- Newport Beach, CA
- Homepage
- https://www.american-vanguard.com
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 4.35% | -6.47% | 5.02% | 0.09% | 36.73% | 33.33% | 12.17% |
| Feb | 14.69% | -1.12% | -7.61% | -2.55% | -15.46% | -9.25% | -3.55% |
| Mar | 0.29% | 36.47% | 4.24% | 19.69% | -9.84% | -46.45% | 0.73% |
| Apr | -5.45% | 1.37% | -10.55% | -11.02% | -4.31% | 18.52% | -1.91% |
| May | -8.37% | 14.37% | -11.65% | -25.66% | 15.76% | -11.03% | -4.43% |
| Jun | -4.58% | -9.62% | 4.87% | -1.83% | -14.97% | 7.69% | -3.07% |
| Jul | -6.62% | 3.86% | -0.17% | 14.12% | -3.26% | -16.43% | -1.42% |
| Aug | -5.78% | -15.66% | -23.48% | -37.61% | 28.27% | -10.57% | -10.80% |
| Sep | -2.59% | -4.88% | -20.57% | -10.17% | 6.30% | -23.58% | -9.25% |
| Oct | 0.84% | 17.70% | -13.41% | 1.95% | -18.13% | -38.86%* | -8.32% |
| Nov | -8.56% | -2.00% | -1.68% | 14.26% | -0.21% | -- | 0.36% |
| Dec | 15.26% | -4.95% | 9.81% | -24.47% | -16.41% | -- | -4.15% |
| Total | -9.62% | 20.81% | -52.45% | -57.34% | -11.58% | -74.31% | -30.75% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall Assessment: NEUTRAL with confidence level (6/10)
Key Drivers:
- Technical indicators suggest a range-bound market, with resistance at $2.37 and support at $2.09.
- Momentum oscillators are neutral, indicating no clear buy or sell signal.
- Beta analysis suggests moderate volatility, with the stock generally following the market.
Primary Risks:
- High IV premium indicates implied richer than realized, suggesting potential for increased volatility.
- Range-bound market may limit upside potential.
Investment Thesis: AVD is currently stuck in a range-bound market, with no clear directional signal. However, the high IV premium suggests potential for increased volatility, making it an attractive option for traders seeking to capitalize on short-term moves.
Recent News Sentiment Impact:
The recent news headlines are neutral, with no significant market-moving events or sentiment shifts impacting the stock price.
Technical Analysis
Trend Direction: Range-bound (1-4 weeks), Medium-term (1-3 months) - no clear uptrend or downtrend
Support/Resistance Levels:
- Resistance: $2.37
- Support: $2.09
Momentum Signals:
- RSI (14): 50.44 (neutral)
- MACD signal: -0.04 / Signal: 0.03 / Histogram: -0.07 (bearish)
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines are neutral, with no significant market-moving events or sentiment shifts impacting the stock price.
Sentiment Assessment: Aggregate news sentiment is neutral, indicating no clear bias in investor opinions.
Catalyst Identification: No upcoming events or earnings releases that could significantly impact the stock price.
Risk & Volatility Assessment
Beta Interpretation: Beta: 0.94 (vs SPY) - moderate volatility, with the stock generally following the market.
Volatility Regime: Moderate volatility (67%) with no clear uptrend or downtrend.
Options Market Signals:
- IV Rank: 17.5% (Low)
- Current IV: 148.0%
- Expected Move: $0.90 (42 DTE), 7-DTE: $0.50
- Volume Flow: 0 calls vs 0 puts
- Open Interest: 0 calls vs 0 puts
Market Context & Positioning
Sector Performance: AVD's sector (Specialty Chemicals) is currently range-bound, with no clear direction.
Institutional Activity: No significant institutional activity or volume patterns suggesting institutional interest.
Correlation Analysis: The stock has a moderate correlation (0.18) with the market, indicating that it generally follows the broader market trends.
Key Levels & Action Items
Critical Price Levels:
- Resistance: $2.37
- Support: $2.09
Breakout/Breakdown Levels: No clear breakout or breakdown levels, as the stock is currently range-bound.
Time-Sensitive Catalysts: No upcoming events or earnings releases that could significantly impact the stock price.
Risk Management: Consider setting stop-loss levels at key support and resistance levels to manage risk. Position sizing should be adjusted based on market conditions and IV premium.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-03-16 | Pre-Market | 3.96% | 0.14% | 0.04x | Within |
| 2021-05-07 | Pre-Market | 9.05% | 1.71% | 0.19x | Within |
| 2021-11-10 | Pre-Market | 4.55% | 0.51% | 0.11x | Within |
| 2022-03-11 | Pre-Market | 4.26% | 1.02% | 0.24x | Within |
| 2022-08-11 | Pre-Market | 7.58% | 1.62% | 0.21x | Within |
| 2023-05-10 | Pre-Market | 7.85% | 13.04% | 1.66x | Exceeded |
| 2023-08-09 | Pre-Market | 8.03% | 16.36% | 2.04x | Exceeded |
| 2023-11-09 | Pre-Market | 9.26% | 2.32% | 0.25x | Within |
| 2024-03-18 | Pre-Market | 10.85% | 9.38% | 0.86x | Within |
| 2024-05-10 | Pre-Market | 12.10% | 27.69% | 2.29x | Exceeded |
| 2024-08-09 | Pre-Market | 11.90% | 37.48% | 3.15x | Exceeded |
| 2024-11-12 | Pre-Market | 14.58% | 4.06% | 0.28x | Within |
| 2025-03-14 | After-Close | 16.37% | 6.77% | 0.41x | Within |
| 2025-06-06 | Pre-Market | 18.52% | 1.65% | 0.09x | Within |
| 2025-08-01 | Pre-Market | 34.33% | 9.07% | 0.26x | Within |
| 2025-11-12 | Pre-Market | 7.70% | 3.29% | 0.43x | Within |
| 2026-03-18 | After-Close | 28.15% | 13.58% | 0.48x | Within |
| 2026-08-10 | Pre-Market | 13.49% | 4.98% | 0.37x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
AVD Options Activity & IV Rank
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 62nd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Above average volatility - stock moves with market amplification
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $995K | #2314 of 3138 | +62.7% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $567K | #3126 of 3716 | new | 13F | |
| Point72 Hedge fund Steve Cohen | $295K | #1727 of 1945 | +17.8% | 13F | |
| Citadel Hedge fund Ken Griffin | $118K | #5715 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
AVD Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | GROUP ONE TRADING LLC Custodian | $1.12K | 100.00% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $47.88K | 100.00% | 2026-06-30 |
AVD Insider Trading (Form 4)
Latest: 2026-08-20| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Cruiser Capital Advisors, LLC | Sell (S) | −1,113,160 | $2.20 | -$2.45M | EDGAR | |
| 2026-08-18 | Steven D Macicek | Director | Buy (P) | +19,000 | $2.09 | $39.7K | EDGAR |
| 2026-07-14 | Douglas Kaye | CHIEF EXECUTIVE OFFICER | Other (J) | +6,527 | $2.36 | $15.4K | EDGAR |
| 2026-06-09 | Keith M Rosenbloom | Director | Award (A) | +31,872 | — | EDGAR | |
| 2026-06-08 | Douglas Kaye | CHIEF EXECUTIVE OFFICER | Grant (A) | +50,000 opt | — | EDGAR | |
| 2026-06-08 | David` T. Johnson | See Remarks | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-06-08 | Rubin J McDougal | Director | Award (A) | +31,872 | — | EDGAR | |
| 2026-06-08 | Douglas Kaye | CHIEF EXECUTIVE OFFICER | Buy (P) | +5,000 | $2.50 | $12.5K | EDGAR |
| 2026-06-05 | Shirin Khosravi | CHRO | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-06-05 | Nolteanous Gilliam | SVP Manufacturing | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-06-05 | Steven D Macicek | Director | Award (A) | +31,872 | — | EDGAR | |
| 2026-06-05 | Timothy J Donnelly | See Remarks | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-06-05 | Jared Straley | SVP Operations & Supply Chain | Grant (A) | +20,000 opt | — | EDGAR | |
| 2026-06-05 | Mark R Bassett | Director | Award (A) | +31,872 | — | EDGAR | |
| 2026-06-05 | Patrick E Gottschalk | Director | Award (A) | +31,872 | — | EDGAR |
AVD Insider Holdings
14 insiders · @ $1.07| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Keith M Rosenbloom | Director | 638,064 | $682.7K | $1.58M | 9 | 2026-06-09 |
| 2 | Douglas Kaye | CHIEF EXECUTIVE OFFICER | 306,778 | $328.3K | $21.8K | 6 | 2026-07-14 |
| 3 | Patrick E Gottschalk | Director | 223,577 | $239.2K | $744.2K | 10 | 2026-06-05 |
| 4 | Steven D Macicek | Director | 99,711 | $106.7K | $188.0K | 7 | 2026-08-18 |
| 5 | Mark R Bassett | Director | 89,919 | $96.2K | $0 | 6 | 2026-06-05 |
| 6 | Timothy J Donnelly | See Remarks | 86,152 | $92.2K | -$940.3K | 34 | 2026-06-05 |
| 7 | Cruiser Capital Advisors, LLC | 81,484 | $87.2K | $2.81M | 12 | 2026-08-20 | |
| 8 | David` T. Johnson | See Remarks | 71,671 | $76.7K | -$868.4K | 34 | 2026-06-08 |
| 9 | Marisol Angelini | Director | 68,762 | $73.6K | $0 | 6 | 2026-06-04 |
| 10 | Scott Baskin | Director | 41,997 | $44.9K | $0 | 13 | 2025-08-08 |
AVD Board & Officers
As of SEC filings through Aug 20, 2026Directors 7
- Marisol Angelini · since Dec 10, 2021
- Keith M Rosenbloom · since Jun 1, 2022
- Mark R Bassett · since Jun 1, 2022
- Patrick E Gottschalk · since Jun 1, 2022
- Steven D Macicek · since Apr 5, 2024
- Rubin J McDougal · since Jun 4, 2026
- Douglas Kaye · listed since Jun 2026
Officers 8
- Douglas Kaye · Chief Executive Officer · listed since Jan 2025
- David` T. Johnson · CFO & Treasurer · listed since Apr 2018
- Michael Joseph DiPaola · Chief Commercial Officer · listed since Jun 2026
- Timothy J Donnelly · CAO, Secretary & General Counsel · listed since Mar 2013
- Peter Eilers · Managing Director, AMVAC Netherlands BV · listed since Apr 2019
- Shirin Khosravi · S. V. P., Human Resources · since Mar 15, 2024
- Jared Straley · SVP Operations & Supply Chain · listed since Jun 2026
- Nolteanous Gilliam · SVP Manufacturing · listed since Jun 2026
Changes in the last 10 years (42)
| Jun 8, 2026 | Douglas Kaye first listed as a director in an SEC filing |
| Jun 5, 2026 | Nolteanous Gilliam first listed as SVP Manufacturing in an SEC filing |
| Jun 5, 2026 | Michael Joseph DiPaola first listed as Chief Commercial Officer in an SEC filing |
| Jun 5, 2026 | Jared Straley first listed as SVP Operations & Supply Chain in an SEC filing |
| Jun 4, 2026 | Rubin J McDougal became a director |
| Apr 10, 2026 | The company announced the departure of de Mino Carmen Tiu from the board in an SEC filing |
| Apr 10, 2026 | The company announced the departure of Scott Baskin from the board in an SEC filing |
| Apr 10, 2026 | The company announced the departure of Emer Gunter from the board in an SEC filing |
| Jan 21, 2025 | Douglas Kaye first listed as Chief Executive Officer in an SEC filing |
| Dec 11, 2024 | de Mino Carmen Tiu became a director |
| Sep 3, 2024 | Eric G Wintemute listed as Chairman (previously Chairman & CEO) in SEC filings |
| Aug 6, 2024 | John Mason Bennett became (Title) Regional Sales Manager, Southeast Region |
| Jul 3, 2024 | The company announced the departure of Eric G Wintemute from the board in an SEC filing |
| Apr 5, 2024 | Steven D Macicek became a director |
| Mar 15, 2024 | Shirin Khosravi became S. V. P., Human Resources |
| Mar 7, 2024 | The company announced the departure of Morton D Erlich from the board in an SEC filing |
| Jul 25, 2023 | Shayne M Wetherall listed as CEO, Envance Technology (previously CEO, Envance Technologies) in SEC filings |
| May 18, 2023 | Cruiser Capital Advisors, LLC no longer listed as a director in SEC filings |
| Mar 1, 2023 | Andrew B Naughton became V.P., Director of Technology |
| Jun 1, 2022 | Patrick E Gottschalk became a director |
| Jun 1, 2022 | Mark R Bassett became a director |
| Jun 1, 2022 | Keith M Rosenbloom became a director |
| Jun 1, 2022 | Cruiser Capital Advisors, LLC became a director |
| Dec 10, 2021 | Marisol Angelini became a director |
| Apr 23, 2021 | Shayne M Wetherall listed as CEO, Envance Technologies (previously CEO Envance Technologies, LLC, TyraTech, Inc, and Amvac Environmental Products) in SEC filings |
| Nov 16, 2020 | Ulrich Trogele listed as COO, Sr. VP AMVAC Chemical Corp. (previously Chief Operating Officer) in SEC filings |
| Nov 16, 2020 | Shayne M Wetherall first listed as CEO Envance Technologies, LLC, TyraTech, Inc, and Amvac Environmental Products in an SEC filing |
| May 7, 2020 | Johann Venter listed as Vice President Technology (AMVA C) (previously Vice President Technology (AMVAC)) in SEC filings |
| Dec 1, 2019 | Emer Gunter became a director |
| Sep 11, 2019 | Suneet Ranganath became V.p. Global Supply Chain & Manufacturing |
| Sep 4, 2019 | Ulrich Trogele listed as Chief Operating Officer (previously COO, Sr. VP AMVAC Chemical Corp.) in SEC filings |
| Apr 1, 2019 | Scott Hendrix listed as SVP Crop Sales, US & Canada (previously VP/US Crop AMVAC Chemical Corp) in SEC filings |
| Apr 1, 2019 | Peter Eilers listed as Managing Director, AMVAC Netherlands BV (previously VP Bus Dev't & Mktg for AMVAC) in SEC filings |
| May 1, 2018 | Jean Pougnier became VP Business Dev. & Marketing |
| Apr 2, 2018 | Peter Porpiglia no longer listed as a director in SEC filings |
| Apr 2, 2018 | John Rizzi listed as Vice President of Manufacturing - AMVAC (previously Vice President Operations (AMVAC)) in SEC filings |
| Apr 2, 2018 | David` T. Johnson listed as CFO & Treasurer (previously Chief Financial Officer) in SEC filings |
| Mar 13, 2018 | Peter Porpiglia first listed as a director in an SEC filing |
| Mar 29, 2017 | Peter Porpiglia became Vice President Product Dev't (AMVAC) |
| Mar 28, 2017 | Anne Turnbough became Vice President/Regulatory Affairs - AMVAC |
| Feb 10, 2017 | Ulrich Trogele listed as COO, Sr. VP AMVAC Chemical Corp. (previously Executive Vice President, COO - AMVAC) in SEC filings |
| Jan 1, 2017 | Peter Eilers became VP Bus Dev't & Mktg for AMVAC |
- Prev
- 1
Not reported recently (18)
- Anne Turnbough · Last reported as Vice President/Regulatory Affairs - AMVAC in an SEC filing dated Sep 5, 2024
- Suneet Ranganath · Last reported as V.p. Global Supply Chain & Manufacturing in an SEC filing dated Sep 5, 2024
- Shayne M Wetherall · Last reported as CEO, Envance Technology in an SEC filing dated Sep 5, 2024
- John Mason Bennett · Last reported as (Title) Regional Sales Manager, Southeast Region in an SEC filing dated Sep 5, 2024
- Eric G Wintemute · Last reported as Chairman in an SEC filing dated Sep 3, 2024
- Debra F. Edwards · Last reported as a director in an SEC filing dated Jun 6, 2024
- Ulrich Trogele · Last reported as COO, Sr. VP AMVAC Chemical Corp. in an SEC filing dated May 17, 2024
- Andrew B Naughton · Last reported as V.P., Director of Technology in an SEC filing dated Jan 25, 2024
- Scott Hendrix · Last reported as SVP Crop Sales, US & Canada in an SEC filing dated Jan 24, 2024
- Peter Porpiglia · Last reported as Vice President Product Dev't (AMVAC) in an SEC filing dated Jan 24, 2024
- John L. Killmer · Last reported as a director in an SEC filing dated Jun 1, 2022
- Esmail Zirakparvar · Last reported as a director in an SEC filing dated Jun 1, 2022
- Alfred F. Ingulli · Last reported as a director in an SEC filing dated Jun 1, 2022
- Johann Venter · Last reported as Vice President Technology (AMVA C) in an SEC filing dated Apr 22, 2022
- Lawrence S Clark · Last reported as a director in an SEC filing dated Jun 4, 2021
- John Rizzi · Last reported as Vice President of Manufacturing - AMVAC in an SEC filing dated Apr 1, 2019
- Jean Pougnier · Last reported as VP Business Dev. & Marketing in an SEC filing dated Apr 1, 2019
- Ad de Jong · Last reported as Managing Director AMVAC Netherlands BV in an SEC filing dated Apr 3, 2018
AVD Proposed Insider Sales (Form 144)
Latest: 2025-09-04What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-09-04 | Eilers Peter | Officer | 6,000 | $32.1K | 2025-09-04 | MERRILL LYNCH | — | EDGAR |
| 2024-12-13 | Eilers Peter | Director | 3,000 | $15.8K | 2024-12-13 | MERRILL LYNCH | — | EDGAR |
| 2024-08-29 | Eilers Peter | Director | 5,000 | $29.0K | 2024-08-29 | MERRILL LYNCH | — | EDGAR |
| 2024-08-29 | WINTEMUTE ERIC G | Director | 100,000 | $576.0K | 2024-08-29 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-08-16 | Eilers Peter | Officer | 6,000 | $91.4K | 2023-08-16 | Merrill Lynch | — | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $1.4M | — | 2026-09-30 |
| 2 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $565,975 | — | 2026-09-30 |
| 3 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.00% | $308,602 | $6.6B | 2026-10-23 |
| 4 | DFSV Dimensional US Small Cap Value ETF | Dimensional | 0.00% | $175,581 | — | 2026-10-23 |
| 5 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $161,923 | — | 2026-10-23 |
| 6 | BSVO EA Bridgeway Omni Small-Cap Value ETF | Nport | 0.01% | $127,039 | — | 2026-06-30 |
| 7 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.01% | $86,828 | $1.2B | 2026-10-23 |
| 8 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.00% | $75,710 | — | 2026-07-31 |
| 9 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $32,756 | — | 2026-10-23 |
| 10 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $17,647 | — | 2026-10-23 |
| 11 | MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF | Nport | 0.00% | $2,810 | — | 2026-05-31 |
| 12 | AVIE Avantis Inflation Focused Equity ETF | Avantis | 0.00% | $23 | $16.6M | 2026-10-23 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $116.75M | $-9.87M | $-0.34 | $-25.02M |
| Q1 '26 | 2026-03-31 | $123.57M | $-4.14M | $-0.14 | $-35.44M |
| Q4 '25 | 2025-12-31 | $150.69M | $-28.21M | $-0.99 | $5.95M |
| Q3 '25 | 2025-09-30 | $119.31M | $-12.36M | $-0.43 | $12.69M |
| Q2 '25 | 2025-06-30 | $129.31M | $-849.00K | $-0.03 | $-19.26M |
| Q1 '25 | 2025-03-31 | $115.80M | $-8.46M | $-0.30 | $-20.58M |
| Q4 '24 | 2024-12-31 | $165.65M | $-90.43M | $-3.24 | $25.40M |
| Q3 '24 | 2024-09-30 | $118.31M | $-25.74M | $-0.91 | $27.88M |
| Q2 '24 | 2024-06-30 | $128.21M | $-11.72M | $-0.42 | $-13.25M |
| Q1 '24 | 2024-03-31 | $135.14M | $1.55M | $0.06 | $-36.11M |
| Q4 '23 | 2023-12-31 | $172.18M | $6.98M | $0.24 | $87.11M |
| Q3 '23 | 2023-09-30 | $149.52M | $-325.00K | $-0.01 | $-49.25M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.